Literature DB >> 12569567

Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase.

Tanya Meyer1, LiHui Xu, Jinli Chang, Edison T Liu, Rolf J Craven, William G Cance.   

Abstract

Rak is a 54 kDa protein tyrosine kinase originally isolated from breast cancer cells and expressed in epithelial cells. It resembles the protooncogene Src structurally but lacks an amino-terminal myristylation site and localizes to the nuclear and perinuclear regions of the cell. We report here that expression of Rak in 2 different breast cancer cell lines inhibits growth and causes G(1) arrest of the cell cycle. This growth inhibition is kinase-dependent but does not require the Rak SH2 or SH3 domain. Rak also binds to the pRb tumor-suppressor protein but inhibits growth even in cells that lack pRb. These results suggest that Rak regulates cell growth by phosphorylating perinuclear proteins and has a function that is distinct from the Src-related kinase family. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569567     DOI: 10.1002/ijc.10925

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

2.  Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine.

Authors:  Andrea Haegebarth; Wenjun Bie; Ruyan Yang; Susan E Crawford; Valeri Vasioukhin; Elaine Fuchs; Angela L Tyner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Authors:  Lei Hua; Ming Zhu; Xu Song; Jun Wang; Zhen Fang; Chunting Zhang; Qiong Shi; Wenjian Zhan; Lei Wang; Qingming Meng; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

4.  FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Authors:  Qiong Shi; Xu Song; Jun Wang; Jia Gu; Weijian Zhang; Jinxia Hu; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-06-27       Impact factor: 3.444

Review 5.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

6.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

7.  Ascorbic acid uptake and regulation of type I collagen synthesis in cultured vascular smooth muscle cells.

Authors:  Huan Qiao; Jason Bell; Saul Juliao; Liying Li; James M May
Journal:  J Vasc Res       Date:  2008-05-31       Impact factor: 1.934

8.  FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.

Authors:  Xiuping Zhou; Lei Hua; Weijian Zhang; Ming Zhu; Qiong Shi; Feng Li; Liexiang Zhang; Chao Song; Rutong Yu
Journal:  J Neurooncol       Date:  2012-07-13       Impact factor: 4.130

9.  Regulation of SRC family kinases in human cancers.

Authors:  Banibrata Sen; Faye M Johnson
Journal:  J Signal Transduct       Date:  2011-04-04

10.  Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.

Authors:  Kaia K Hampton; Rolf J Craven
Journal:  Oncoscience       Date:  2014-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.